{"@id":"https://bioecon.ru/technology/in-vivo-high-throughput-antibody-discovery/","@type":"Technology","cluster":"therapeutics-platforms","formats":{"html":"https://en.bioecon.ru/technology/in-vivo-high-throughput-antibody-discovery/","json":"https://en.bioecon.ru/api/v1/technology/in-vivo-high-throughput-antibody-discovery/index.json"},"id":"in-vivo-high-throughput-antibody-discovery","industries":["pharma","biomanufacturing"],"lang":"en","links":{"industries":["https://bioecon.ru/industries/pharma/","https://bioecon.ru/industries/biomanufacturing/"],"suppliers":["https://bioecon.ru/companies/novartis/","https://bioecon.ru/companies/lonza-group/","https://bioecon.ru/companies/genmab/","https://bioecon.ru/companies/tsingke-biotechnology/","https://bioecon.ru/companies/becton-dickinson/","https://bioecon.ru/companies/allozymes/","https://bioecon.ru/companies/vland-biotech/","https://bioecon.ru/companies/jiangsu-hengrui-medicine/","https://bioecon.ru/companies/caladan-bio/","https://bioecon.ru/companies/daiichi-sankyo/"]},"maturity":7,"name":"In-Vivo High-Throughput Antibody Discovery","regions":["ch","eu","us","cn"],"risk":"medium","section":"technology","sector":"health-biomedicine","sources":[{"date":"2026-11-22","entity":"Swiss Biotech Directory 2026","kind":"vendor","urls":["https://www.swissbiotech.org/directory/"]}],"stages":[{"n":1,"title":"Target immunization campaigns"},{"n":2,"title":"Droplet single-cell secretome assay"},{"n":3,"title":"Optical droplet sorting"},{"n":4,"title":"Rapid variable gene cloning"}],"summary":"Automated immunization and droplet-microfluidic interrogation of millions of single plasma cells directly from immunized animal lymph nodes, rapidly isolating high-affinity antibodies against challenging multipass membrane proteins.","url":"/technology/in-vivo-high-throughput-antibody-discovery/","verified":"2026-11-22"}